Ricoh USA, Inc. has announced the formation of a new company, Ricoh 3D for Healthcare, LLC, dedicated to rapidly growing the adoption of FDA-cleared, patient-specific medical devices. With hospitals facing rising pressure to deliver patient-specific medical devices quickly and efficiently, Ricoh says it is committed to democratising access to advanced healthcare technologies, empowering hospitals to move up the value chain.
Driven by a rising demand for customised and patient-specific solutions according to the company, the market for 3D printed medical devices is projected to grow from 5.59 billion USD in 2025 to 24.69 billion USD by 2034. This new company will provide greater agility to address this rapid growth, focus on the unique needs of clinical customers, and help drive regulatory guidance and standardisation.
“The establishment of Ricoh 3D for Healthcare is the natural next step in the evolution of a business Ricoh has been incubating for five years,” said Gary Turner, Vice President and General Manager, Ricoh 3D for Healthcare. “As we rapidly scale and enter an accelerated growth phase of the business, it is essential that we have the right structure in place to realise and maximise the potential that Ricoh has envisioned for this business from the beginning.”
Ricoh 3D for Healthcare delivers a full continuum of patient-specific solutions—from FDA (Food and Drug Administration)-cleared anatomic models to on-site, point-of-care manufacturing studios that facilitate hospitals’ ability to have regulated devices manufactured inside their own walls.
Beyond hospital programs, Ricoh 3D for Healthcare collaborates with emerging medical technology innovators, such as Kallisio (oral stents for head and neck cancer) and Insight Surgery (oncology and osteotomy surgical guides), to manufacture and distribute next-generation, patient-specific devices nationwide. These combined efforts position Ricoh 3D for Healthcare at the centre of a rapidly expanding ecosystem that is redefining personalised care.
Precision healthcare is receiving increased attention. The FDA continues to develop regulatory frameworks for 3D as well as review and clear personalised 3D printed implants and surgical tools. Momentum is also building for reimbursement, with a growing number of CPT (Current Procedural Terminology) and HCPCS (Healthcare Common Procedure Coding System) codes to cover 3D visualisation, planning and printing.
“Ricoh 3D for Healthcare is a pioneer in this industry. An example is our point-of-care 3D medical device manufacturing facility at Atrium Health, which gives clinicians immediate access to 3D printed anatomic models and support,” said Turner. “Our ability to operate independently will allow us to accelerate similar types of innovation, facilitating opportunities to partner, innovate and collaborate.”
Like this:
Like Loading…
Related